Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 7Brain Neoplasms 7Neoplasm Metastasis 6Recurrence 5Glioma 5Glioblastoma 5Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Head and Neck Neoplasms 4Sarcoma 3Neoplasms 3Leukemia 3Colorectal Neoplasms 3Breast Neoplasms 3Astrocytoma 3Uveal Melanoma 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms, Neuroepithelial 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Melanoma 2Diffuse Intrinsic Pontine Glioma 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Solid Tumor Malignancies 1

Interventions

Pemetrexed 22Cisplatin 20Nivolumab 8Gemcitabine 7Carboplatin 7durvalumab 5Ipilimumab 5Bevacizumab 5pembrolizumab 4Radiotherapy, Intensity-Modulated 4tremelimumab 3niraparib 3Oxaliplatin 3Drug Therapy 3Cyclophosphamide 3Cerebral Decortication 3Blood Specimen Collection 3sargramostim 2Thoracoscopy 2Surveys and Questionnaires 2Sorafenib 2Radiosurgery 2Magnesium Sulfate 2Leucovorin 2Imatinib Mesylate 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2Dexamethasone 2tislelizumab 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mesothelioma × Valproic Acid × Clear all
NCT00634205 2015-02-12

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

European Lung Cancer Working Party

Phase 2 Completed
45 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡